Literature DB >> 715179

Effects of hyperthermia on the cycling, noncycling, and hypoxic cells of irradiated and unirradiated multicell spheroids.

R E Durand.   

Abstract

Entities:  

Mesh:

Year:  1978        PMID: 715179

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


× No keyword cloud information.
  8 in total

Review 1.  Hypoxia-driven immunosuppression: a new reason to use thermal therapy in the treatment of cancer?

Authors:  Chen-Ting Lee; Thomas Mace; Elizabeth A Repasky
Journal:  Int J Hyperthermia       Date:  2010       Impact factor: 3.914

Review 2.  Drug and radiation resistance in spheroids: cell contact and kinetics.

Authors:  P L Olive; R E Durand
Journal:  Cancer Metastasis Rev       Date:  1994-06       Impact factor: 9.264

Review 3.  Multicellular spheroids. A review on cellular aggregates in cancer research.

Authors:  W Mueller-Klieser
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

4.  Cell-cell contact affects cellular sensitivity to hyperthermia.

Authors:  J Dobrucki; N M Bleehen
Journal:  Br J Cancer       Date:  1985-12       Impact factor: 7.640

5.  Thermotolerance in chinese hamster cells under oxic conditions after chronic culture under hypoxia.

Authors:  S Rajaratnam; E Smith; I J Stratford; G E Adams
Journal:  Br J Cancer       Date:  1981-04       Impact factor: 7.640

6.  3D tumour spheroids for the prediction of the effects of radiation and hyperthermia treatments.

Authors:  Sarah C Brüningk; Ian Rivens; Carol Box; Uwe Oelfke; Gail Ter Haar
Journal:  Sci Rep       Date:  2020-02-03       Impact factor: 4.379

Review 7.  Therapeutic response differences between 2D and 3D tumor models of magnetic hyperthermia.

Authors:  Ruby Gupta; Deepika Sharma
Journal:  Nanoscale Adv       Date:  2021-05-05

8.  The response to cytotoxic drugs of EMT6 cells treated either as intact or disaggregated spheroids.

Authors:  T T Kwok; P R Twentyman
Journal:  Br J Cancer       Date:  1985-02       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.